Login / Signup

Soluble suppression of tumourigenicity 2 as a predictor of postoperative hepatic failure.

Jing WuShadike ApaerXiapukaiti FulatiDominique A VuittonYunfei ZhangJiangduosi PayiziwulaNuerzhatijiang AnweierTao LiKahaer TuerxunTuerganaili AjiJinming ZhaoYingmei ShaoTuerhongjiang TuxunHao Wen
Published in: BJS open (2024)
Soluble suppression of tumourigenicity 2 may be a reliable predictor of posthepatectomy liver failure ≥ grade B as early as postoperative day 1 for patients undergoing liver resection. Its role in controlling hepatic injury/regeneration needs further investigation. Registration number: ChiCTR-OOC-15007210 (www.chictr.org.cn/).
Keyphrases
  • patients undergoing
  • liver failure
  • hepatitis b virus
  • stem cells
  • lymph node metastasis